Abstract
PerkinElmer has agreed to acquire Caliper Life Sciences, a company providing imaging and detection solutions to the life sciences research, diagnostics and environmental markets, for US$10.50 per share or a total cash purchase price of approximately US$600 M. The transaction has been approved by the Boards of Directors of both companies and is expected to close in the fourth quarter of 2011. The acquisition will expand PerkinElmer’s product portfolio with the addition of complementary offerings with applications in fields such as genomics, translational medicine research and biotherapeutics development.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
